In a study published this week, researchers presented a Simoa-based assay for tuberculosis that could ultimately be packaged as a point-of-care test.
After years of frustration, researchers can now more definitively link a polio-like syndrome to prior infection with two common respiratory viruses.
Inqaba will distribute DNAStar's Lasergene software suite for DNA, RNA, and protein sequence analysis in Africa.
The grant will fund development of methods using the company's IsoLight system to study protein signaling pathways in single tumor cells.
The company delivered organic growth across its four business segments and raised its revenue and earnings guidance for the year.
Under the 10-year deal, SomaLogic will analyze at least 250,000 clinical samples to support Novartis' drug development work and its own test development.
The study is one of several recent efforts to detect bacteria directly with mass spec, which could eliminate the need for culturing and speed turnaround time.
While the approach lost some of its luster after failing to deliver on early hype, technological improvements are revitalizing interest among researchers.
The method could prove useful both for studying tumor immunology and in the development of cancer immunotherapies, said one of the researchers.
While Canopy has traditionally focused on genomic technologies, the April acquisition gives it a foothold in the single-cell protein imaging space.
The partners will more thoroughly connect Protein Metrics' software suite and Sciex's high-resolution accurate mass (HRAM) spectrometry systems.
The Swiss company markets the WAVE system, a waveguide interferometry-based instrument for studying molecular interactions in real time.
Gathering last week in Australia, the community continued its years-long push towards increased clinical relevance and integration with other omics disciplines.
The instrument's ability to run in negative-ion mode allows it to move beyond its traditional focus on proteins and into the analysis of other analyte classes.
BioStream will distribute the company's IsoCode and IsoLight products, which enable highly multiplexed protein measurements at the single-cell level.
The approach uses miniaturized sample prep and isobaric tagging and can identify up to 2,300 proteins in single cells and analyze around 100 cells per day.
Under the deal, Mobilion is implementing its SLIM ion mobility technology on Agilent's QTOF mass specs, with a broad commercial launch planned for 2021.
Developed using the center's "industrialized" proteomics workflow, the panel identified patients up to a year before their diagnosis with 89 percent accuracy.
The partners plan to develop a number of liquid chromatography mass spectrometry methods for clinical research applications.
The company hopes to develop AI-based tools to improve the usefulness of its ESCAPE platform, which combines single-cell sequencing with protein analysis.
Nature News reports that gene therapy approaches are tackling sickle cell disease, but that the cost of treatment is a concern.
The Washington Post reports that a US Senate committee voted this week to approve the nomination of Stephen Hahn to lead the Food and Drug Administration.
One gene regulates hundreds of others to influence facial development, according to New Scientist.
In Nature this week: resources for single-cell analysis, little overlap in the microRNAs used by Salmonella and Shigella to infect host cells, and more.